Several drugs are being tried for mitigating the COVID-19 symptoms including dapagliflozin (SGLT2-antidiabetic) lopinavir/ritonavir, darunavir/umifenovir (anti-HIV), remdesivir (anti-Ebola), favipiravir and dipyridamole (anti-hypertensive). This evidence concerns the gene SLC5A2 and COVID-19.